Your browser doesn't support javascript.
loading
Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer.
Williams, Terence M; Flecha, Athena R; Keller, Paul; Ram, Ashwin; Karnak, David; Galbán, Stefanie; Galbán, Craig J; Ross, Brian D; Lawrence, Theodore S; Rehemtulla, Alnawaz; Sebolt-Leopold, Judith.
Affiliation
  • Williams TM; Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan, USA. Terence.Williams@osumc.edu
Mol Cancer Ther ; 11(5): 1193-202, 2012 May.
Article in En | MEDLINE | ID: mdl-22411900
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Radiation-Sensitizing Agents / Signal Transduction / Mitogen-Activated Protein Kinases / Enzyme Inhibitors / Phosphoinositide-3 Kinase Inhibitors Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Radiation-Sensitizing Agents / Signal Transduction / Mitogen-Activated Protein Kinases / Enzyme Inhibitors / Phosphoinositide-3 Kinase Inhibitors Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2012 Document type: Article Affiliation country: United States Country of publication: United States